Article info
PDFArticle
Use of ulipristal acetate, levonorgestrel and the copper-intrauterine device for emergency contraception following the introduction of new FSRH guidelines
- Correspondence to Dr Aisling Susan Baird, Liverpool Community Health, Central Abacus, Citrus House, 40–46 Dale Street, Liverpool L2 5SF, UK; aisling.baird{at}liverpoolch.nhs.uk
Citation
Use of ulipristal acetate, levonorgestrel and the copper-intrauterine device for emergency contraception following the introduction of new FSRH guidelines
Publication history
- Received August 26, 2012
- Revised January 12, 2013
- Accepted January 29, 2013
- First published April 25, 2013.
Online issue publication
May 13, 2016
Article Versions
- Previous version (13 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions